Updated throughout the day.

Genzyme (NASDAQ: GENZ) may consider a deal structure to allow Sanofi-Aventis to buy the company (WSJ)

The US will launch a massive insider trading case against scores of Wall St. executives, bankers, and traders (WSJ)

Douglas A. McIntyre